Hammer Fiber Optics Holdings Corp. (OTCQB: HMMR), a
telecommunications company investing in the future of wireless technology, is
preparing for the anticipated roll out of 5G wireless upgrades this year. An
article further discussing the company reads: “As the world prepares for
next-generation 5G wireless cell service (http://ibn.fm/g4B9D), telecommunications company Hammer
Fiber Optics Holdings Corp. (OTCQB: HMMR) is building its efforts to grow its
New Jersey, New York and Pennsylvania base of operations into a national
program that will provide service on a neighborhood-access basis. The company
is aligning itself with like-minded businesses as it works to deliver low-cost,
high-capacity broadband to phone, Internet and television service markets
across the country. …The company plans to begin live field testing of its new
“pre-5G” system this year to coincide with the earliest rollout of the
transformational 5G technology in select parts of the United States, with
commercial service to follow in the coming months.”
To view the full article, visit http://ibn.fm/gGgBK
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
